953039-25-3 Usage
Description
6-Bromo-2-chloro-8-fluoroquinazoline, with the molecular formula C8H4BrClF2N2, is a quinazoline derivative that incorporates bromine, chlorine, and fluorine atoms within its structure. 6-BroMo-2-chloro-8-fluoroquinazoline is recognized for its unique molecular configuration and reactivity, positioning it as a promising building block in the synthesis of a variety of organic compounds and pharmaceuticals. Its versatility and potential applications in research and development, as well as in the production of advanced materials and fine chemicals, make it a valuable asset in the realm of organic chemistry.
Uses
Used in Pharmaceutical Research and Development:
6-Bromo-2-chloro-8-fluoroquinazoline serves as a key intermediate in the synthesis of new drugs, leveraging its unique molecular structure to contribute to the development of pharmaceuticals with novel therapeutic properties. Its presence in the molecular framework of potential drug candidates can influence pharmacokinetics, pharmacodynamics, and overall drug efficacy.
Used in Organic Synthesis:
As a quinazoline derivative with multiple halogens, 6-Bromo-2-chloro-8-fluoroquinazoline is utilized in organic synthesis for the creation of complex organic molecules. Its reactivity allows for various chemical reactions, such as cross-coupling and substitution, facilitating the construction of diverse chemical libraries.
Used in the Production of Advanced Materials:
6-BroMo-2-chloro-8-fluoroquinazoline's unique properties make it suitable for the development of advanced materials with specific characteristics required in high-tech industries. Its potential use in material science includes the creation of new polymers, coatings, or other materials with tailored properties for applications in electronics, aerospace, or other sectors.
Used in Fine Chemicals Industry:
6-Bromo-2-chloro-8-fluoroquinazoline is employed in the fine chemicals industry for the production of specialty chemicals that have high added value. Its role in this industry could involve the synthesis of high-purity compounds for use in fragrances, dyes, or other niche applications where the unique properties of the compound are advantageous.
Check Digit Verification of cas no
The CAS Registry Mumber 953039-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,3,0,3 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 953039-25:
(8*9)+(7*5)+(6*3)+(5*0)+(4*3)+(3*9)+(2*2)+(1*5)=173
173 % 10 = 3
So 953039-25-3 is a valid CAS Registry Number.
953039-25-3Relevant articles and documents
TREATMENT OF FIBROSIS WITH IRE1 SMALL MOLECULE INHIBITORS
-
, (2020/11/30)
Provided herein are methods of using IRE1 small molecule inhibitors in combination therapies for treating fibrosis in a subject. The IRE1 small molecule inhibitors described herein may be used in combination therapies for treating fibrosis
IRE1 SMALL MOLECULE INHIBITORS
-
, (2019/05/30)
Provided herein are small molecule inhibitors for the targeting or IRE1 protein family members. Binding may be direct or indirect. Further provided herein are methods of using IRE1 small molecule inhibitors for use in treating or ameliorating cancer in a subject. Moreover, IRE1 small molecule inhibitors described herein are for the treatment of cancer, where the cancer is a solid or hematologic cancer.
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
-
, (2014/02/15)
Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.
